Sai Parenterals Limited
Press Release
01 / The disclosure
What the company shared
Sai Parenterals Limited has informed the Exchange regarding a press release dated October 05, 2026, titled "Sai Parenterals Completes the Acquisition of R&D Facility Prathyak Laboratories".
A question for your research
Check transaction size, funding, dilution, approvals and completion conditions before assessing the earnings impact.
Numbers found in document text 2 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
60%Page 2
Investor Release Hyderabad, 05, October 2026 – Sai Parenterals Limited has completed the acquisition of 60% equity stake in Prathyak Laboratories Private Limited, an operating research and development centre at Genome Valley, Hyderabad, for Rs. 15 crore, funded from the unutilised net proceeds of the Company's initial public offering.
View source pageRs. 15 crorePage 2
Investor Release Hyderabad, 05, October 2026 – Sai Parenterals Limited has completed the acquisition of 60% equity stake in Prathyak Laboratories Private Limited, an operating research and development centre at Genome Valley, Hyderabad, for Rs. 15 crore, funded from the unutilised net proceeds of the Company's initial public offering.
View source pageThe evidence
Read the source excerpts
01Dear Sir/Madam, Unit: Sai Parenterals Limited Subject: Press Release Pursuant to Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that the Company has issued a Press Release titled “Sai Parenterals Completes the Acquisition of R&D Facility Prathyak Laboratories”.
Page 1
02Investor Release Hyderabad, 05, October 2026 – Sai Parenterals Limited has completed the acquisition of 60% equity stake in Prathyak Laboratories Private Limited, an operating research and development centre at Genome Valley, Hyderabad, for Rs. 15 crore, funded from the unutilised net proceeds of the Company's initial public offering.
Page 2
03Sai Parenterals Limited Sai Parenterals Completes the Acquisition of R&D Facility Prathyak Laboratories 1 The acquisition replaces the greenfield research centre the Company had originally intended to build and for which an allocation had been earmarked in the objects of the issue.
Page 2
04Acquisition of an operating platform rather than constructing one allows development work to begin immediately.
Page 2
05Formulations developed at this R&D centre can be taken into commercial production as the Company’s injectable capacity is expanded and upgraded, shortening the path from development to supply in regulated and semi-regulated markets.
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106807008
- First collected
- 5 Oct 2026, 22:51 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- 2a0be7d8f3c264dc3d781c9ccdead6e4cb8f190d537a21516c895e400c1eddc1